Charles Schwab’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.42M | Buy |
|
|||||
|
2024
Q3 | $4.1M | Buy |
|
|||||
|
2024
Q2 | $1.93M | Buy |
|
|||||
|
2024
Q1 | $3.44M | Buy |
|
|||||
|
2023
Q4 | $5.95M | Buy |
|
|||||
|
2023
Q3 | $7.61M | Buy |
|
|||||
|
2023
Q2 | $15.9M | Buy |
|
|||||
|
2023
Q1 | $19.6M | Buy |
|
|||||
|
2022
Q4 | $11.2M | Buy |
|
|||||
|
2022
Q3 | $15.4M | Buy |
|
|||||
|
2022
Q2 | $6.66M | Sell |
|
|||||
|
2022
Q1 | $9.58M | Buy |
|
|||||
|
2021
Q4 | $7.78M | Buy |
|
|||||
|
2021
Q3 | $13.1M | Buy |
|
|||||
|
2021
Q2 | $13.9M | Buy |
|
|||||
|
2021
Q1 | $12.5M | Buy |
|
|||||
|
2020
Q4 | $11.6M | Buy |
|
|||||
|
2020
Q3 | $10.2M | Buy |
|
|||||
|
2020
Q2 | $8.21M | Buy |
|
|||||
|
2020
Q1 | $4.52M | Buy |
|
|||||
|
2019
Q4 | $4.37M | Buy |
|
|||||
|
2019
Q3 | $3.19M | Buy |
|
|||||
|
2019
Q2 | $3.15M | Buy |
|
|||||
|
2019
Q1 | $3.55M | Buy |
|
|||||
|
2018
Q4 | $3.56M | Sell |
|
|||||
|
2018
Q3 | $4.42M | Buy |
|
|||||
|
2018
Q2 | $4.2M | Buy |
|
|||||
|
2018
Q1 | $4.15M | Buy |
|
|||||
|
2017
Q4 | $4.23M | Buy |
|
|||||
|
2017
Q3 | $3.23M | Buy |
|
|||||
|
2017
Q2 | $2.95M | Buy |
|
|||||
|
2017
Q1 | $1.92M | Buy |
|
|||||
|
2016
Q4 | $1.83M | Buy |
|
|||||
|
2016
Q3 | $968K | Sell |
|
|||||
|
2016
Q2 | $902K | Buy |
|
|||||
|
2016
Q1 | $1.13M | Buy |
|
|||||
|
2015
Q4 | $2.17M | Buy |
|
|||||
|
2015
Q3 | $1.4M | Buy |
|
|||||
|
2015
Q2 | $1.16M | Buy |
|
|||||
|
2015
Q1 | $553K | Buy |
|
|||||
|
2014
Q4 | $427K | Buy |
|
|||||
|
2014
Q3 | $373K | Buy |
|
|||||
|
2014
Q2 | $525K | Buy |
|